Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Benjamin Kester

Sports Medicine Lombard, IL Medical Doctor

NPI 1568851251 CMS profile 7588714

1801 S Highland Ave Ste 220, Lombard, IL 60148

Open in the dashboard

General payments

$56,083

107 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Kester of Lombard, IL is reported in the CMS Open Payments database as having received $56,083 across 107 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,048 10
2024 General $3,342 26
2023 General $810 9
2022 General $2,956 13
2021 General $15,738 41
2020 General $32,189 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Kester
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Benjamin Kester were reported at $1,048. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Benjamin Kester Sports Medicine median Middle half National median
2019 $0 $1,176 $199–$4,249 $163
2020 $32,189 $708 $96–$2,890 $114
2021 $15,738 $1,213 $152–$3,994 $132
2022 $2,956 $1,230 $159–$3,998 $149
2023 $810 $584 $146–$2,836 $160
2024 $3,342 $628 $163–$3,168 $164
2025 $1,048 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Smith+Nephew, Inc. $23,023 3 payments
  2. Arthrex, Inc. $20,198 3 payments
  3. Stryker Corporation $4,579 36 payments
  4. Encore Medical, LP $3,336 29 payments
  5. Medwest Associates $3,038 8 payments
  6. Vericel Corporation $1,027 16 payments
  7. Exactech, Inc. $224 2 payments
  8. Miach Orthopaedics, Inc. $191 1 payment
  9. DePuy Synthes Sales Inc. $158 3 payments
  10. Linvatec Corporation $126 3 payments
  11. Other $183 3 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Education $25,847 5 payments
  2. Grant $20,000 1 payment
  3. Food and Beverage $5,493 70 payments
  4. Travel and Lodging $3,108 29 payments
  5. Consulting Fee $1,500 1 payment
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $134 1 payment
Products named General payments · program years 2020–2025
  1. DJO Surgical AltiVate Anatomic System $2,163 24 payments
  2. DJO Surgical AltiVate Reverse $2,012 2 payments
  3. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $1,184 9 payments
  4. MACI $1,027 16 payments
  5. PROCINCH $616 1 payment
  6. INSPACE $566 3 payments
  7. PANGEA $526 4 payments
  8. DJO SURGICAL $439 1 payment
  9. T2 $334 3 payments
  10. T2 ALPHA $311 2 payments
  11. Other $2,191 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

296

Median for Orthopedic Surgery: 203

Drug cost

$1,595

Median for Orthopedic Surgery: $1,433

Branded share of claims

26.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 38 $414
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 34 $240
Methylprednisolone Generic 50 $216
Acetaminophen-Codeine Acetaminophen With Codeine Brand 45 $206
Meloxicam Generic 50 $151
Cyclobenzaprine Hcl Generic 22 $142
Tramadol Hcl Generic 31 $95
Oxycodone Hcl Generic 13 $89
Ondansetron Hcl Generic 13 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$192,661

Of which drugs: $5,097

Medicare patients

524

Average age 76

Services billed

4,176

314 women, 210 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 63%
Ischemic heart disease 36%
Chronic kidney disease 29%
Depression 27%
Diabetes 26%
Heart failure 22%
Atrial fibrillation 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 109 767 $542

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

107 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record